JENNIFER MALLOY: Open Payments
NPI 1265983563 · TIMONIUM, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,247 in 51 payments from 24 companies in 2025. Trend: 2023 $1,349 · 2024 $1,743 · 2025 $1,247
Food & beverage: $1,223Education: $24
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 6 | $243 |
| SANOFI-AVENTIS U.S. LLC | 3 | $87 |
| RECORDATI_RARE_DISEASES_INC. | 4 | $77 |
| CeQur Corporation | 1 | $67 |
| Lilly USA, LLC | 4 | $64 |
| Tandem Diabetes Care, Inc. | 2 | $63 |
| Novo Nordisk Inc | 3 | $62 |
| Antares Pharma, Inc. | 3 | $58 |
| Radius Health, Inc. | 3 | $56 |
| ABBVIE INC. | 3 | $54 |
Products named: Korlym, TZIELD, ISTURISA, CeQur Simplicity, MOUNJARO, t:slim X2 Insulin Pump with Control-IQ, XYOSTED, CRENESSITY.
Industry payments across MD — which companies pay providers there.
